DESTINE: Decision Support Tool in Endovascular Therapy

Cloud-based software that gets ischemic stroke patients to the right hospital for treatment as fast as possible.

Destine: Decision Support Tool in Endovascular Therapy

DESTINE health software application

Ischemic strokes are caused by an obstruction in a blood vessel to the brain. Typically a drug is administered to dissolve the clot. But a new procedure, Endovascular Therapy (EVT), is proven to be more effective. Using imaging, surgeons and interventionalists use a retrievable stent to remove the blood clot. But every second counts—during a stroke about 2 million brain cells die every minute--so it’s imperative to get the patient to an urban hospital for EVT as fast as possible.

BME researchers have developed DESTINE, an interactive geographic software that shows the best transport option for ischemic stroke patients to access EVT. The cloud-based software interfaces with Google’s Distance Matrix API and ARC GIS, a geographic information system. DESTINE will optimize outcomes for stroke patients, increase access to EVT and reduce costs to the healthcare system.

Dr. Noreen Kamal (Co-lead), Adjunct Assistant Professor, Department of Clinical Neurosciences, Cumming School of Medicine and Department of Electrical and Computer Engineering, Schulich School of Engineering

Jessalyn Holodinsky (Co-lead), PhD Candidate, Department of Community Health Sciences, Cumming School of Medicine

Dr. Michael Hill, Professor, Departments of Clinical Neurosciences, Community Health Sciences, Medicine and Radiology, Cumming School of Medicine 
Member, Hotchkiss Brain Institute and the O'Brien Institute for Public Health

Dr. Mayank Goyal, Professor, Departments of Radiology and Clinical Neurosciences, Cumming School of Medicine 
Director, Imaging and Endovascular Treatment, Calgary Stroke Program 
Member, Hotchkiss Brain Institute 
Partner, EFW Radiology

Dr. Anders Nygren, Associate Professor, Department of Electrical and Computer Engineering, Schulich School of Engineering 
Associate Dean, Academic and Planning, Schulich School of Engineering

Destine: Decision Support Tool in Endovascular Therapy

Jessalyn Holodinsky (left), PhD Candidate in the Cumming School of Medicine, and Dr. Noreen Kamal (right), project lead

Destine: Decision Support Tool in Endovascular Therapy

DESTINE health software application